Study ID | Number | Study Title | Institute | Species | Analysis |
---|---|---|---|---|---|
ST000242 | 1 metabolites | Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium | Mayo Clinic | Homo sapiens | MS |
ST000286 | 1 metabolites | Mouse skeletal myotube chronic low-frequency stimulation | University of Florida | Mus musculus | MS |
ST000291 | 2 metabolites | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | University of Florida | Homo sapiens | MS |
ST000292 | 1 metabolites | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | University of Florida | Homo sapiens | MS |
ST000403 | 2 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Monash University | Homo sapiens | MS |
ST000414 | 1 metabolites | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Monash University | Plasmodium falciparum | MS |
ST000539 | 2 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Monash University | Homo sapiens | MS |
ST000546 | 1 metabolites | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Monash University | Plasmodium falciparum | MS |
ST000549 | 1 metabolites | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Mayo Clinic | Mus musculus | MS |
ST001033 | 1 metabolites | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Monash University | Plasmodium falciparum | MS |
ST001122 | 1 metabolites | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | University of California, Davis | Homo sapiens | MS |
ST001201 | 1 metabolites | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001202 | 1 metabolites | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001204 | 1 metabolites | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001205 | 1 metabolites | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001274 | 1 metabolites | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Monash University | Trypanosoma brucei brucei | MS |
ST001304 | 1 metabolites | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Monash University | Toxoplasma gondii | MS |
ST001315 | 1 metabolites | Retargeting azithromycin-like compounds as antimalarials with dual modality | Monash University | Plasmodium falciparum | MS |
ST001547 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages | Monash University | Homo sapiens | MS |
ST001548 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-II) | Monash University | Homo sapiens | MS |
ST001549 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-III) | Monash University | Homo sapiens | MS |
ST001658 | 1 metabolites | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Johns Hopkins University | Saccharomyces cerevisiae | MS |
ST001788 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Monash University | Homo sapiens | MS |
ST001844 | 1 metabolites | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | University of California, Davis | Homo sapiens | MS |
ST001961 | 1 metabolites | Metabolomics of brown adipose tissue in murine heart failure model | Juntendo University | Mus musculus | MS |
ST002010 | 1 metabolites | Chemoresistant Ovarian Cancer Global Metabolomics | The University of South Australia | Homo sapiens | MS |
ST002066 | 1 metabolites | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | The Walter and Eliza Hall Institute of Medical Research | Mus musculus | MS |
ST002094 | 4 metabolites | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Mayo Clinic | Homo sapiens | MS |
ST002104 | 1 metabolites | Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations | Future Industries Institute | Homo sapiens | MS |
ST002107 | 1 metabolites | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Monash University | Plasmodium falciparum | MS |
ST002108 | 1 metabolites | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Monash University | Plasmodium falciparum | MS |
ST002170 | 1 metabolites | Cecal metabolome of specific-pathogen-free mice fed with five distinct rodent diets with varying fiber content and source. | Luxembourg Institute of Health | Mus musculus | MS |
ST002171 | 1 metabolites | Serum metabolome of specific-pathogen-free mice fed with five distinct rodent diets with varying fiber content and source. | Luxembourg Institute of Health | Mus musculus | MS |
ST002172 | 1 metabolites | Cecal metabolome of gnotobiotic (containing a 14-member synthetic human gut microbiota), and germ-free mice fed with two distinct rodent diets with varying fiber content. | Luxembourg Institute of Health | Mus musculus | MS |
ST002212 | 1 metabolites | Human fecal metabolome profiles under 3 different dietary terms | Keio University | Homo sapiens | MS |
ST002309 | 1 metabolites | Targeting malaria parasites with novel derivatives of azithromycin | Monash University | Plasmodium falciparum | MS |
ST002323 | 1 metabolites | SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia | Chiba University | Homo sapiens | MS |
ST002405 | 1 metabolites | Stool global metabolite levels in peanut allergy (Part 2) | Icahn School of Medicine at Mount Sinai | Homo sapiens | MS |
ST002412 | 1 metabolites | Metabolic effects of the protein kinase R | Hudson | Mus musculus | MS |
ST002476 | 1 metabolites | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection | Keio University | Mus musculus | MS |
ST002479 | 1 metabolites | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Hamster) | Keio University | Mesocricetus Auratus | MS |
ST002493 | 1 metabolites | Composition of raw plant-based food items Pilot Study | Massachusetts Institute of Technology | Malus domestica/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Allium sativum/Ocimum basilicum | MS |
ST002698 | 2 metabolites | Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites | Peter Doherty Institute for Infection and Immunity | Plasmodium berghei | MS |
ST002759 | 2 metabolites | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Medical College of Wisconsin | Rattus norvegicus | MS |
ST002760 | 2 metabolites | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Medical College of Wisconsin | Rattus norvegicus | MS |
ST002761 | 1 metabolites | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Medical College of Wisconsin | Rattus norvegicus | MS |
ST002792 | 1 metabolites | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Monash University | Plasmodium falciparum | MS |
ST002926 | 1 metabolites | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Monash University | Plasmodium falciparum | MS |
ST003036 | 2 metabolites | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Monash Institute of Pharmaceutical Sciences | Pseudomonas aeruginosa | MS |
ST003053 | 2 metabolites | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Monash University | Staphylococcus aureus | MS |
ST003084 | 1 metabolites | Metabolome changes in embryonic CSF (Part 6) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003085 | 1 metabolites | Metabolome changes in embryonic CSF (Part 7) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003086 | 1 metabolites | Metabolome changes in embryonic CSF (Part 8) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003087 | 2 metabolites | Metabolome changes in embryonic CSF (Part 9) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003088 | 1 metabolites | Metabolome changes in embryonic CSF (Part 10) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003089 | 1 metabolites | Metabolome changes in embryonic CSF (Part 11) | Boston Children's Hospital, Harvard Medical School | Mus musculus | MS |
ST003179 | 1 metabolites | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Monash University | Plasmodium falciparum | MS |